US Stock MarketDetailed Quotes

NYMXF Nymox Pharmaceutical

Watchlist

0.200
+0.020+11.11%

15min DelayClose Jul 3 13:00 ET

18.65MMarket Cap-4000P/E (TTM)

Nymox Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

Total revenue

0.00%-5K

-5K

Operating revenue

--0

0.00%-5K

--0

---5K

Cost of revenue

Gross profit

0.00%-5K

-5K

Operating expense

-31.53%1.01M

-38.06%1.1M

-72.70%1.39M

-46.80%6.65M

-160.47%-1.69M

-55.09%1.48M

-55.42%1.78M

108.89%5.07M

6.68%12.5M

40.52%2.79M

Selling and administrative expenses

-40.07%353K

-47.62%506K

-10.14%665K

-50.75%2.88M

-60.51%577K

-59.63%589K

-49.58%966K

-26.29%740K

62.34%5.85M

80.37%1.46M

-Selling and marketing expense

--0

----

--0

----

-General and administrative expense

-40.07%353K

-47.62%506K

-10.14%665K

-50.75%2.88M

-60.51%577K

-59.63%589K

-49.58%966K

-26.29%740K

62.34%5.85M

80.37%1.46M

Research and development costs

-25.90%661K

-26.67%594K

-83.39%720K

-43.33%3.77M

-270.54%-2.26M

-51.50%892K

-60.83%810K

204.14%4.33M

-18.00%6.66M

13.03%1.33M

Operating profit

31.53%-1.01M

38.06%-1.1M

72.70%-1.39M

46.80%-6.65M

160.19%1.68M

55.09%-1.48M

55.42%-1.78M

-108.89%-5.07M

-6.69%-12.5M

-40.78%-2.79M

Net non-operating interest income expense

-120.00%-22K

-900.00%-10K

83.33%-2K

-35.48%-42K

-30.00%-26K

-10K

83.33%-1K

-20.00%-12K

-106.67%-31K

50.00%-20K

Non-operating interest income

----

--2K

-87.50%1K

----

-70.37%8K

----

Non-operating interest expense

----

-66.67%2K

10.26%43K

----

-45.45%6K

-7.14%39K

----

Total other finance cost

120.00%22K

900.00%10K

-66.67%2K

----

--10K

-83.33%1K

--6K

----

Other net income (expense)

6,000.00%118K

-3M

3.12M

33.33%-2K

Gain on sale of security

----

350.00%5K

----

33.33%-2K

----

Other non- operating income (expenses)

----

--113K

---3M

----

--3.12M

----

Income before tax

30.52%-1.04M

-182.84%-1.11M

72.73%-1.39M

47.55%-6.58M

52.35%-1.34M

54.79%-1.49M

133.58%1.34M

-108.53%-5.09M

-6.81%-12.54M

-38.63%-2.81M

Income tax

Net income

30.52%-1.04M

-182.84%-1.11M

72.73%-1.39M

47.55%-6.58M

52.35%-1.34M

54.79%-1.49M

133.58%1.34M

-108.53%-5.09M

-6.81%-12.54M

-38.63%-2.81M

Net income continuous Operations

30.52%-1.04M

-182.84%-1.11M

72.73%-1.39M

47.55%-6.58M

52.35%-1.34M

54.79%-1.49M

133.58%1.34M

-108.53%-5.09M

-6.81%-12.54M

-38.63%-2.81M

Minority interest income

Net income attributable to the parent company

30.52%-1.04M

-182.84%-1.11M

72.73%-1.39M

47.55%-6.58M

52.35%-1.34M

54.79%-1.49M

133.58%1.34M

-108.53%-5.09M

-6.81%-12.54M

-38.63%-2.81M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

30.52%-1.04M

-182.84%-1.11M

72.73%-1.39M

47.55%-6.58M

52.35%-1.34M

54.79%-1.49M

133.58%1.34M

-108.53%-5.09M

-6.81%-12.54M

-38.63%-2.81M

Basic earnings per share

50.00%-0.01

-200.00%-0.01

66.67%-0.02

53.33%-0.07

66.67%-0.01

50.00%-0.02

120.00%0.01

-100.00%-0.06

6.25%-0.15

0.00%-0.03

Diluted earnings per share

50.00%-0.01

-200.00%-0.01

66.67%-0.02

53.33%-0.07

66.67%-0.01

50.00%-0.02

120.00%0.01

-100.00%-0.06

6.25%-0.15

0.00%-0.03

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021
Total revenue	0	0	0	0	0.00%-5K	0	0	0	0	-5K
Operating revenue	--0	--0	--0	--0	0.00%-5K	--0	--0	--0	--0	---5K
Cost of revenue	0	0	0	0	0	0	0	0	0	0
Gross profit	0	0	0	0	0.00%-5K	0	0	0	0	-5K
Operating expense	-31.53%1.01M	-38.06%1.1M	-72.70%1.39M	-46.80%6.65M	-160.47%-1.69M	-55.09%1.48M	-55.42%1.78M	108.89%5.07M	6.68%12.5M	40.52%2.79M
Selling and administrative expenses	-40.07%353K	-47.62%506K	-10.14%665K	-50.75%2.88M	-60.51%577K	-59.63%589K	-49.58%966K	-26.29%740K	62.34%5.85M	80.37%1.46M
-Selling and marketing expense	--0	--0	----	----	----	--0	--0	----	----	----
-General and administrative expense	-40.07%353K	-47.62%506K	-10.14%665K	-50.75%2.88M	-60.51%577K	-59.63%589K	-49.58%966K	-26.29%740K	62.34%5.85M	80.37%1.46M
Research and development costs	-25.90%661K	-26.67%594K	-83.39%720K	-43.33%3.77M	-270.54%-2.26M	-51.50%892K	-60.83%810K	204.14%4.33M	-18.00%6.66M	13.03%1.33M
Operating profit	31.53%-1.01M	38.06%-1.1M	72.70%-1.39M	46.80%-6.65M	160.19%1.68M	55.09%-1.48M	55.42%-1.78M	-108.89%-5.07M	-6.69%-12.5M	-40.78%-2.79M
Net non-operating interest income expense	-120.00%-22K	-900.00%-10K	83.33%-2K	-35.48%-42K	-30.00%-26K	-10K	83.33%-1K	-20.00%-12K	-106.67%-31K	50.00%-20K
Non-operating interest income	----	----	--2K	-87.50%1K	----	----	----	----	-70.37%8K	----
Non-operating interest expense	----	----	-66.67%2K	10.26%43K	----	----	----	-45.45%6K	-7.14%39K	----
Total other finance cost	120.00%22K	900.00%10K	-66.67%2K	----	----	--10K	-83.33%1K	--6K	----	----
Other net income (expense)				6,000.00%118K	-3M		3.12M		33.33%-2K
Gain on sale of security	----	----	----	350.00%5K	----	----	----	----	33.33%-2K	----
Other non- operating income (expenses)	----	----	----	--113K	---3M	----	--3.12M	----	----	----
Income before tax	30.52%-1.04M	-182.84%-1.11M	72.73%-1.39M	47.55%-6.58M	52.35%-1.34M	54.79%-1.49M	133.58%1.34M	-108.53%-5.09M	-6.81%-12.54M	-38.63%-2.81M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	30.52%-1.04M	-182.84%-1.11M	72.73%-1.39M	47.55%-6.58M	52.35%-1.34M	54.79%-1.49M	133.58%1.34M	-108.53%-5.09M	-6.81%-12.54M	-38.63%-2.81M
Net income continuous Operations	30.52%-1.04M	-182.84%-1.11M	72.73%-1.39M	47.55%-6.58M	52.35%-1.34M	54.79%-1.49M	133.58%1.34M	-108.53%-5.09M	-6.81%-12.54M	-38.63%-2.81M
Minority interest income
Net income attributable to the parent company	30.52%-1.04M	-182.84%-1.11M	72.73%-1.39M	47.55%-6.58M	52.35%-1.34M	54.79%-1.49M	133.58%1.34M	-108.53%-5.09M	-6.81%-12.54M	-38.63%-2.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	30.52%-1.04M	-182.84%-1.11M	72.73%-1.39M	47.55%-6.58M	52.35%-1.34M	54.79%-1.49M	133.58%1.34M	-108.53%-5.09M	-6.81%-12.54M	-38.63%-2.81M
Basic earnings per share	50.00%-0.01	-200.00%-0.01	66.67%-0.02	53.33%-0.07	66.67%-0.01	50.00%-0.02	120.00%0.01	-100.00%-0.06	6.25%-0.15	0.00%-0.03
Diluted earnings per share	50.00%-0.01	-200.00%-0.01	66.67%-0.02	53.33%-0.07	66.67%-0.01	50.00%-0.02	120.00%0.01	-100.00%-0.06	6.25%-0.15	0.00%-0.03
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

Concept

Top Gainers Yesterday

Intraday+5.53%